This residue plays an important role in LOX-PP functions because its mutation in glutamine inhibits the adipogenic effect of LOX-PP14 and impairs the ability of LOX-PP to inhibit the invasive phenotype and tumor formation of breast cancer cells42. This evidence concerns the gene LOX and breast carcinoma.